Over the last 7 days, the Biotech industry has remained flat, although notably Innovent Biologics gained 7.0%. As for the longer term, the industry has declined 37% in the last year. Looking forward, earnings are forecast to grow by 36% annually.
Has the Hong Kong Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Sat, 15 Jun 2024 | HK$339.0b | HK$49.7b | -HK$19,479,313,074.00 | 10.5x | -17.4x | 6.8x |
Mon, 13 May 2024 | HK$381.6b | HK$49.9b | -HK$19,280,058,128.71 | 12.4x | -19.8x | 7.6x |
Wed, 10 Apr 2024 | HK$348.5b | HK$49.3b | -HK$19,515,680,148.97 | 11x | -17.9x | 7.1x |
Fri, 08 Mar 2024 | HK$335.4b | HK$47.2b | -HK$20,389,266,599.64 | 15.3x | -16.4x | 7.1x |
Sun, 04 Feb 2024 | HK$298.0b | HK$46.8b | -HK$20,180,773,943.00 | 15x | -14.8x | 6.4x |
Tue, 02 Jan 2024 | HK$409.5b | HK$47.3b | -HK$20,423,453,967.00 | 17.7x | -20.1x | 8.7x |
Thu, 30 Nov 2023 | HK$408.3b | HK$46.5b | -HK$18,752,881,282.00 | 19x | -21.8x | 8.8x |
Sat, 28 Oct 2023 | HK$397.2b | HK$44.9b | -HK$19,035,005,211.00 | 13.4x | -20.9x | 8.8x |
Mon, 25 Sep 2023 | HK$413.2b | HK$44.9b | -HK$18,918,406,180.00 | 16.5x | -21.8x | 9.2x |
Wed, 23 Aug 2023 | HK$370.9b | HK$35.9b | -HK$22,907,163,046.00 | 14.7x | -16.2x | 10.3x |
Fri, 21 Jul 2023 | HK$389.8b | HK$35.5b | -HK$23,381,657,031.00 | 25.4x | -16.7x | 11x |
Sun, 18 Jun 2023 | HK$420.9b | HK$35.8b | -HK$23,587,907,883.00 | 25.5x | -17.8x | 11.8x |
Tue, 16 May 2023 | HK$446.8b | HK$36.5b | -HK$24,154,441,532.00 | 31.6x | -18.5x | 12.2x |
Thu, 13 Apr 2023 | HK$457.4b | HK$37.0b | -HK$24,166,995,434.00 | 18.8x | -18.9x | 12.4x |
Sat, 11 Mar 2023 | HK$384.0b | HK$32.9b | -HK$36,072,787,903.00 | 23.3x | -10.6x | 11.7x |
Mon, 06 Feb 2023 | HK$474.1b | HK$35.0b | -HK$35,372,745,817.00 | 30.7x | -13.4x | 13.6x |
Wed, 04 Jan 2023 | HK$421.5b | HK$34.3b | -HK$34,558,058,099.00 | 27.1x | -12.2x | 12.3x |
Fri, 02 Dec 2022 | HK$358.3b | HK$33.3b | -HK$33,534,642,762.00 | 21.9x | -10.7x | 10.8x |
Sun, 30 Oct 2022 | HK$326.1b | HK$31.6b | -HK$32,117,634,240.00 | 15.3x | -10.2x | 10.3x |
Tue, 27 Sep 2022 | HK$285.3b | HK$33.7b | -HK$32,905,028,932.00 | 20.5x | -8.7x | 8.5x |
Thu, 25 Aug 2022 | HK$319.2b | HK$33.6b | -HK$41,231,286,975.00 | 11.7x | -7.7x | 9.5x |
Sat, 23 Jul 2022 | HK$355.9b | HK$32.8b | -HK$46,264,777,795.00 | 13.9x | -7.7x | 10.8x |
Mon, 20 Jun 2022 | HK$346.7b | HK$33.0b | -HK$46,543,563,472.00 | 14.2x | -7.4x | 10.5x |
Wed, 18 May 2022 | HK$337.1b | HK$33.9b | -HK$45,711,035,896.00 | 13.3x | -7.4x | 9.9x |
Fri, 15 Apr 2022 | HK$348.1b | HK$36.4b | -HK$46,232,583,949.00 | 13.6x | -7.5x | 9.6x |
Sun, 13 Mar 2022 | HK$303.1b | HK$34.0b | -HK$31,197,209,607.00 | 12.7x | -9.7x | 8.9x |
Tue, 08 Feb 2022 | HK$303.1b | HK$31.1b | -HK$31,825,745,693.00 | 11.9x | -9.5x | 9.7x |
Thu, 06 Jan 2022 | HK$352.4b | HK$31.1b | -HK$31,791,809,096.00 | 12.8x | -11.1x | 11.3x |
Sat, 04 Dec 2021 | HK$475.4b | HK$31.0b | -HK$31,771,215,941.00 | 13.5x | -15x | 15.3x |
Mon, 01 Nov 2021 | HK$470.3b | HK$30.8b | -HK$31,564,064,070.00 | 14.3x | -14.9x | 15.2x |
Wed, 29 Sep 2021 | HK$517.0b | HK$30.5b | -HK$31,485,203,054.00 | 15.1x | -16.4x | 17x |
Fri, 27 Aug 2021 | HK$492.3b | HK$30.2b | -HK$32,058,827,347.35 | 16.7x | -15.4x | 16.3x |
Sat, 03 Jul 2021 | HK$651.9b | HK$30.2b | -HK$32,058,827,347.35 | 19.7x | -20.3x | 21.6x |
-20.3x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | -1.82% | |
Healthcare | -0.71% | |
Biotech | 0.54% | |
Biotech | 0.54% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1801 Innovent Biologics | HK$38.30 | 7.0% +HK$4.1b | 4.4% | PS9.3x | |
9995 RemeGen | HK$27.40 | 6.6% +HK$914.5m | -25.5% | PS11x | |
6855 Ascentage Pharma Group International | HK$23.05 | 10.8% +HK$642.4m | 3.8% | PS27.5x | |
2162 Keymed Biosciences | HK$35.30 | 6.8% +HK$622.4m | -22.1% | PS25.6x | |
2179 Jiangsu Recbio Technology | HK$9.05 | 14.7% +HK$555.8m | -36.3% | PS132.6x |